1)Gavin PJ, Suseno MT, Thomson RB Jr, et al:Clinical
correlation of the CLSI susceptibility breakpoint for pipera-cillin- tazobactam against extended-spectrum-beta-lacta-mase-producing Escherichia coli and Klebsiella species. Antimicrob Agents Chemother 50:2244-2247,2006
2)Clinical and Laboratory Standards Institute:M100-S22-U: Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement, Clinical and Laboratory Standards Institute, Wayne, PA,2012
3)Mermel LA, Allon M, Bouza E, et al:Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49:1-45,2009
4)O’Grady NP, Alexander M, Burns LA, et al:Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52:e162-e193,2011